Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WWC1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | ZNF880 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | FAHD2A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | PLEKHM2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | DYM | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | FAM210B | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | MORN1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | RPL24 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | FURIN | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
mRNA | UBR5 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |